Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment

被引:1
作者
Wisialowski, Todd A. [1 ,10 ]
Ether, Nick [2 ]
Foley, Michael [3 ]
Kleiman, Robert [4 ]
Koshman, Yevgeniya [3 ]
Leishman, Derek [5 ]
Martel, Eric [6 ]
Nichols, Jill, V [7 ]
Popp, Julia [7 ]
Rajamani, Sridharan [8 ]
Riley, Steve [1 ]
Rossman, Eric I. [9 ]
Vargas, Hugo M. [2 ]
机构
[1] Pfizer, Groton, CT USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] AbbVie, N Chicago, IL USA
[4] Clario, Philadelphia, PA USA
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] Boehringer Ingelheim Pharm GmbH & Co KG, Biberach An Der Riss, Germany
[7] LabCorp, Madison, WI USA
[8] Johnson & Johnson Innovat Med, San Diego, CA USA
[9] GSK, Collegeville, PA USA
[10] Pfizer Res & Dev, Drugs Safety Res & Dev, Groton, CT 06340 USA
关键词
Canine; Cardiovascular; Concentration-response modeling; ICH E14/S7BQ&As; In vivo; Moxifloxacin; Nonhuman primate; QTc prolongation; Safety pharmacology; Telemetry; MOXIFLOXACIN; PROLONGATION;
D O I
10.1016/j.vascn.2024.107515
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页数:7
相关论文
共 21 条
  • [1] [Anonymous], 2022, ICH E14S7B IMPLEMENT
  • [2] Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysis
    Chui, Ray W.
    Baublits, Joel
    Chandra, Fiona A.
    Jones, Zack W.
    Engwall, Michael J.
    Vargas, Hugo M.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2379 - 2390
  • [3] Results From the IQ-CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase
    Darpo, B.
    Benson, C.
    Dota, C.
    Ferber, G.
    Garnett, C.
    Green, C. L.
    Jarugula, V.
    Johannesen, L.
    Keirns, J.
    Krudys, K.
    Liu, J.
    Ortemann-Renon, C.
    Riley, S.
    Sarapa, N.
    Smith, B.
    Stoltz, R. R.
    Zhou, M.
    Stockbridge, N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (04) : 326 - 335
  • [4] The IQ-CSRC Prospective Clinical Phase 1 Study: "Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?"
    Darpo, Borje
    Sarapa, Nenad
    Garnett, Christine
    Benson, Charles
    Dota, Corina
    Ferber, Georg
    Jarugula, Venkateswar
    Johannesen, Lars
    Keirns, James
    Krudys, Kevin
    Ortemann-Renon, Catherine
    Riley, Steve
    Rogers-Subramaniam, Danise
    Stockbridge, Norman
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2014, 19 (01) : 70 - 81
  • [5] Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration-QTc analysis
    Engwall, Michael J.
    Baublits, Joel
    Chandra, Fiona A.
    Jones, Zack W.
    Wahlstrom, Jan
    Chui, Ray W. W.
    Vargas, Hugo M.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (03): : 436 - 446
  • [6] Reference intervals and method sensitivity for electrocardiology, hemodynamics, and body temperature parameters in healthy cynomolgus monkeys
    Fang, Xiefan
    Tichenor, Stephen D.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 120
  • [7] Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies
    Florian, Jeffry A.
    Tornoe, Christoffer W.
    Brundage, Richard
    Parekh, Ameeta
    Garnett, Christine E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (08) : 1152 - 1162
  • [8] Garnett C, 2018, J PHARMACOKINET PHAR, V45, P383, DOI 10.1007/s10928-017-9558-5
  • [9] Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing
    Gotta, Verena
    Cools, Frank
    van Ammel, Karel
    Gallacher, David J.
    Visser, SandraA. G.
    Sannajust, Frederick
    Morissette, Pierre
    Danhof, Meindert
    van der Graaf, Piet H.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2015, 72 : 1 - 10
  • [10] Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human
    Komatsu, Ryuichi
    Mizuno, Hiroshi
    Ishizaka, Tomomichi
    Ito, Akihito
    Jikuzono, Tatsuya
    Kakoi, Tadashi
    Bando, Masahiro
    Koga, Tadashi
    Handa, Jun
    Takahashi, Yukio
    Kanno, Akihiro
    Ozaki, Harushige
    Chiba, Katsuyoshi
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99